https://scholars.lib.ntu.edu.tw/handle/123456789/503555
標題: | Do we still need lead-in dosing of Nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy? | 作者: | SUI-YUAN CHANG SHU-WEN LIN CHIEN-CHING HUNG |
公開日期: | 2009 | 卷: | 49 | 期: | 9 | 起(迄)頁: | 1452-1453 | 來源出版物: | Clinical Infectious Diseases | URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/503555 | ISSN: | 1058-4838 | DOI: | 10.1086/644494 | SDG/關鍵字: | efavirenz; nevirapine; rifampicin; drug blood level; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; letter; priority journal; tuberculosis; vertical transmission; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。